Recent Finacing
Recent Raise
GeneAssess is a New Jersey biotechnology company developing FRY, a cancer molecular-signature gene and diagnostic biomarker, focused on validating it for cancer staging.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor